Theravance Biopharma (TBPH) Competitor Comparison
We are evaluating the key criteria listed to compare Theravance Biopharma (TBPH) against its competitors in the Biotechnology industry.
Market Capitalization
175 / 368Gross Profits
162 / 278Total Revenue
116 / 300EBITDA
157 / 337Free Cashflow
311 / 352Quick Ratio
157 / 357Earnings per Share
129 / 359Dividend yield
0 / 6Total Cash
194 / 358Performance 3 years
84 / 368Performance 5 years
169 / 368Performance 10 years
137 / 368Linearity 3 years
18 / 368Linearity 5 years
89 / 368Linearity 10 years
44 / 368Total Rank
12 / 368Dividend Rank
30 / 368Valuation Rank
239 / 368Piotroski Rank
25 / 368Muliplier Rank
98 / 368Market Capitalization - TBPH ranking 175 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.